KevinLoringWinthropMD

Infectious Disease • Portland, OR

Assistant Professor, Ophthalmology, Oregon Health and Science University School of Medicine

Join to view full profile

Are you Dr. Winthrop?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 47 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
3375 SW Terwilliger Blvd
Portland, OR 97239
Phone+1 503-494-7890

Fax+1 503-494-0470

Summary

Dr. Kevin Winthrop, MD is an infectious disease specialist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Washington, and Florida. He is affiliated with Portland HCS and OHSU Hospital.

Education & Training

Legacy Health/Emanuel Medical CenterResidency, Internal Medicine, 2004 - 2006
California Department of Public HealthFellowship, Maxillofacial Pathology, 2002 - 2002
Oregon Health and Science University School of MedicineClass of 1998

Certifications & Licensure

CA State Medical License 1999 - Present
WA State Medical License 2024 - 2026
OR State Medical License 2004 - 2025
FL State Medical License 2018 - 2020
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria Start of enrollment: 2012 Apr 19
Completed
Phase 2
A PILOT STUDY OF THE SAFETY AND EFFECTIVENESS OF THE LIVE ZOSTER VACCINE IN ANTI-TNF USERS Start of enrollment: 2014 May 01
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) Start of enrollment: 2016 May 01
Completed
Phase 2
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE) Start of enrollment: 2013 Oct 01
Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis Start of enrollment: 2016 Oct 28
Completed
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Start of enrollment: 2017 Apr 11
Recruiting
Phase 2
Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease Start of enrollment: 2016 Oct 01
Completed
Phase 2
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease Start of enrollment: 2019 Feb 22
Recruiting
Phase 2, Phase 3
A Study of Opaganib in Coronavirus Disease 2019 Pneumonia Start of enrollment: 2020 Jul 02
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Corrigendum to Risk of Corneal Graft Rejection and Vaccination: A Matched Case-Control Study From a United States Integrated Health Care System Am J Ophthalmol 2024 Ju...
Jennifer H Ku, Afshan A Nanji, Julia E Tubert, Cynthia Joe, Divya Srikumaran
American Journal of Ophthalmology. 2024-12-01
Choosing Wisely: Effectiveness and Safety of Antibiotic Prophylaxis in Close Contacts of Invasive Group A Streptococci Infection.
Marina G Birck, Cristiano S Moura, Kevin L Winthrop, Marina A A Machado, Autumn Neville
Clinical Infectious Diseases. 2024-11-26
: Three-year Mortality Following Prescription of Multidrug Antibiotic Treatment forPulmonary Disease in United States Medicare Beneficiaries With Bronchiectasis.
Cara D Varley, Jennifer H Ku, Emily Henkle, Luke Strnad, Kevin L Winthrop
Open Forum Infectious Diseases. 2024-11-01

Press Mentions

Adjuvant Recombinant Zoster Vaccine Immunogenicity in Patients with RA Aged ≥50 Years Treated with a JAKi. Watch DrDecember 16th, 2024
Adjuvant Recombinant Zoster Vaccine Immunogenicity in Patients with RA Aged ≥50 Years Treated with a JAKi. Watch DrDecember 9th, 2024
Adjuvant Recombinant Zoster Vaccine Immunogenicity in Patients with RA Aged ≥50 Years Treated with a JAKi. Watch DrDecember 3rd, 2024
Join now to see all

Grant Support

Mycobacterial Disease Prevention: Pharmacovigilance And Inflammatory DiseaseAgency For Healthcare Research And Quality2008–2010